Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy (Q36318871)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy
scientific article

    Statements

    Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy (English)
    Seung Tae Kim
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Won Ki Kang
    Ho Yeong Lim
    23 March 2017

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit